Global Immune-Mediated Inflammatory Diseases Treatment Market Size, Status and Forecast 2020-2026
SKU ID : QYR-15312658 | Publishing Date : 20-Feb-2020 | No. of pages : 90
Detailed TOC of Global Immune-Mediated Inflammatory Diseases Treatment Market Size, Status and Forecast 2020-2026
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Immune-Mediated Inflammatory Diseases Treatment Revenue
1.4 Market Analysis by Type
1.4.1 Global Immune-Mediated Inflammatory Diseases Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Targeted biologic therapies
1.4.3 Novel therapies
1.5 Market by Application
1.5.1 Global Immune-Mediated Inflammatory Diseases Treatment Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Pharmacy Store
1.5.4 Online Pharmacy
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends by Regions
2.1 Immune-Mediated Inflammatory Diseases Treatment Market Perspective (2015-2026)
2.2 Immune-Mediated Inflammatory Diseases Treatment Growth Trends by Regions
2.2.1 Immune-Mediated Inflammatory Diseases Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Immune-Mediated Inflammatory Diseases Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Immune-Mediated Inflammatory Diseases Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Immune-Mediated Inflammatory Diseases Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Immune-Mediated Inflammatory Diseases Treatment Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Immune-Mediated Inflammatory Diseases Treatment Players by Market Size
3.1.1 Global Top Immune-Mediated Inflammatory Diseases Treatment Players by Revenue (2015-2020)
3.1.2 Global Immune-Mediated Inflammatory Diseases Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Immune-Mediated Inflammatory Diseases Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Immune-Mediated Inflammatory Diseases Treatment Market Concentration Ratio
3.2.1 Global Immune-Mediated Inflammatory Diseases Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Immune-Mediated Inflammatory Diseases Treatment Revenue in 2019
3.3 Immune-Mediated Inflammatory Diseases Treatment Key Players Head office and Area Served
3.4 Key Players Immune-Mediated Inflammatory Diseases Treatment Product Solution and Service
3.5 Date of Enter into Immune-Mediated Inflammatory Diseases Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global Immune-Mediated Inflammatory Diseases Treatment Historic Market Size by Type (2015-2020)
4.2 Global Immune-Mediated Inflammatory Diseases Treatment Forecasted Market Size by Type (2021-2026)
5 Immune-Mediated Inflammatory Diseases Treatment Breakdown Data by Application (2015-2026)
5.1 Global Immune-Mediated Inflammatory Diseases Treatment Market Size by Application (2015-2020)
5.2 Global Immune-Mediated Inflammatory Diseases Treatment Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Immune-Mediated Inflammatory Diseases Treatment Market Size (2015-2020)
6.2 Immune-Mediated Inflammatory Diseases Treatment Key Players in North America (2019-2020)
6.3 North America Immune-Mediated Inflammatory Diseases Treatment Market Size by Type (2015-2020)
6.4 North America Immune-Mediated Inflammatory Diseases Treatment Market Size by Application (2015-2020)
7 Europe
7.1 Europe Immune-Mediated Inflammatory Diseases Treatment Market Size (2015-2020)
7.2 Immune-Mediated Inflammatory Diseases Treatment Key Players in Europe (2019-2020)
7.3 Europe Immune-Mediated Inflammatory Diseases Treatment Market Size by Type (2015-2020)
7.4 Europe Immune-Mediated Inflammatory Diseases Treatment Market Size by Application (2015-2020)
8 China
8.1 China Immune-Mediated Inflammatory Diseases Treatment Market Size (2015-2020)
8.2 Immune-Mediated Inflammatory Diseases Treatment Key Players in China (2019-2020)
8.3 China Immune-Mediated Inflammatory Diseases Treatment Market Size by Type (2015-2020)
8.4 China Immune-Mediated Inflammatory Diseases Treatment Market Size by Application (2015-2020)
9 Japan
9.1 Japan Immune-Mediated Inflammatory Diseases Treatment Market Size (2015-2020)
9.2 Immune-Mediated Inflammatory Diseases Treatment Key Players in Japan (2019-2020)
9.3 Japan Immune-Mediated Inflammatory Diseases Treatment Market Size by Type (2015-2020)
9.4 Japan Immune-Mediated Inflammatory Diseases Treatment Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Immune-Mediated Inflammatory Diseases Treatment Market Size (2015-2020)
10.2 Immune-Mediated Inflammatory Diseases Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Immune-Mediated Inflammatory Diseases Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Immune-Mediated Inflammatory Diseases Treatment Market Size by Application (2015-2020)
11 India
11.1 India Immune-Mediated Inflammatory Diseases Treatment Market Size (2015-2020)
11.2 Immune-Mediated Inflammatory Diseases Treatment Key Players in India (2019-2020)
11.3 India Immune-Mediated Inflammatory Diseases Treatment Market Size by Type (2015-2020)
11.4 India Immune-Mediated Inflammatory Diseases Treatment Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Immune-Mediated Inflammatory Diseases Treatment Market Size (2015-2020)
12.2 Immune-Mediated Inflammatory Diseases Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Immune-Mediated Inflammatory Diseases Treatment Market Size by Type (2015-2020)
12.4 Central & South America Immune-Mediated Inflammatory Diseases Treatment Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 GlaxoSmithKline
13.1.1 GlaxoSmithKline Company Details
13.1.2 GlaxoSmithKline Business Overview and Its Total Revenue
13.1.3 GlaxoSmithKline Immune-Mediated Inflammatory Diseases Treatment Introduction
13.1.4 GlaxoSmithKline Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2015-2020))
13.1.5 GlaxoSmithKline Recent Development
13.2 Eli Lilly
13.2.1 Eli Lilly Company Details
13.2.2 Eli Lilly Business Overview and Its Total Revenue
13.2.3 Eli Lilly Immune-Mediated Inflammatory Diseases Treatment Introduction
13.2.4 Eli Lilly Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2015-2020)
13.2.5 Eli Lilly Recent Development
13.3 AstraZeneca
13.3.1 AstraZeneca Company Details
13.3.2 AstraZeneca Business Overview and Its Total Revenue
13.3.3 AstraZeneca Immune-Mediated Inflammatory Diseases Treatment Introduction
13.3.4 AstraZeneca Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2015-2020)
13.3.5 AstraZeneca Recent Development
13.4 Bristol-Myers
13.4.1 Bristol-Myers Company Details
13.4.2 Bristol-Myers Business Overview and Its Total Revenue
13.4.3 Bristol-Myers Immune-Mediated Inflammatory Diseases Treatment Introduction
13.4.4 Bristol-Myers Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2015-2020)
13.4.5 Bristol-Myers Recent Development
13.5 Sanofi
13.5.1 Sanofi Company Details
13.5.2 Sanofi Business Overview and Its Total Revenue
13.5.3 Sanofi Immune-Mediated Inflammatory Diseases Treatment Introduction
13.5.4 Sanofi Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2015-2020)
13.5.5 Sanofi Recent Development
13.6 Roche
13.6.1 Roche Company Details
13.6.2 Roche Business Overview and Its Total Revenue
13.6.3 Roche Immune-Mediated Inflammatory Diseases Treatment Introduction
13.6.4 Roche Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2015-2020)
13.6.5 Roche Recent Development
13.7 Enlivex Therapeutics
13.7.1 Enlivex Therapeutics Company Details
13.7.2 Enlivex Therapeutics Business Overview and Its Total Revenue
13.7.3 Enlivex Therapeutics Immune-Mediated Inflammatory Diseases Treatment Introduction
13.7.4 Enlivex Therapeutics Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2015-2020)
13.7.5 Enlivex Therapeutics Recent Development
13.8 Immune Pharmaceuticals
13.8.1 Immune Pharmaceuticals Company Details
13.8.2 Immune Pharmaceuticals Business Overview and Its Total Revenue
13.8.3 Immune Pharmaceuticals Immune-Mediated Inflammatory Diseases Treatment Introduction
13.8.4 Immune Pharmaceuticals Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2015-2020)
13.8.5 Immune Pharmaceuticals Recent Development
13.9 Tanabe Pharma
13.9.1 Tanabe Pharma Company Details
13.9.2 Tanabe Pharma Business Overview and Its Total Revenue
13.9.3 Tanabe Pharma Immune-Mediated Inflammatory Diseases Treatment Introduction
13.9.4 Tanabe Pharma Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2015-2020)
13.9.5 Tanabe Pharma Recent Development
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
List of Figures, Tables and Charts Available in Global Immune-Mediated Inflammatory Diseases Treatment Market Size, Status and Forecast 2020-2026
List of TablesTable 1. Immune-Mediated Inflammatory Diseases Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Immune-Mediated Inflammatory Diseases Treatment Revenue
Table 3. Ranking of Global Top Immune-Mediated Inflammatory Diseases Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Immune-Mediated Inflammatory Diseases Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Targeted biologic therapies
Table 6. Key Players of Novel therapies
Table 7. Global Immune-Mediated Inflammatory Diseases Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Immune-Mediated Inflammatory Diseases Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Immune-Mediated Inflammatory Diseases Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Immune-Mediated Inflammatory Diseases Treatment Market Share by Regions (2015-2020)
Table 11. Global Immune-Mediated Inflammatory Diseases Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Immune-Mediated Inflammatory Diseases Treatment Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Immune-Mediated Inflammatory Diseases Treatment Market Growth Strategy
Table 17. Main Points Interviewed from Key Immune-Mediated Inflammatory Diseases Treatment Players
Table 18. Global Immune-Mediated Inflammatory Diseases Treatment Revenue by Players (2015-2020) (Million US$)
Table 19. Global Immune-Mediated Inflammatory Diseases Treatment Market Share by Players (2015-2020)
Table 20. Global Top Immune-Mediated Inflammatory Diseases Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Immune-Mediated Inflammatory Diseases Treatment as of 2019)
Table 21. Global Immune-Mediated Inflammatory Diseases Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Immune-Mediated Inflammatory Diseases Treatment Product Solution and Service
Table 24. Date of Enter into Immune-Mediated Inflammatory Diseases Treatment Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Immune-Mediated Inflammatory Diseases Treatment Market Size by Type (2015-2020) (Million US$)
Table 27. Global Immune-Mediated Inflammatory Diseases Treatment Market Size Share by Type (2015-2020)
Table 28. Global Immune-Mediated Inflammatory Diseases Treatment Revenue Market Share by Type (2021-2026)
Table 29. Global Immune-Mediated Inflammatory Diseases Treatment Market Size Share by Application (2015-2020)
Table 30. Global Immune-Mediated Inflammatory Diseases Treatment Market Size by Application (2015-2020) (Million US$)
Table 31. Global Immune-Mediated Inflammatory Diseases Treatment Market Size Share by Application (2021-2026)
Table 32. North America Key Players Immune-Mediated Inflammatory Diseases Treatment Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Immune-Mediated Inflammatory Diseases Treatment Market Share (2019-2020)
Table 34. North America Immune-Mediated Inflammatory Diseases Treatment Market Size by Type (2015-2020) (Million US$)
Table 35. North America Immune-Mediated Inflammatory Diseases Treatment Market Share by Type (2015-2020)
Table 36. North America Immune-Mediated Inflammatory Diseases Treatment Market Size by Application (2015-2020) (Million US$)
Table 37. North America Immune-Mediated Inflammatory Diseases Treatment Market Share by Application (2015-2020)
Table 38. Europe Key Players Immune-Mediated Inflammatory Diseases Treatment Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Immune-Mediated Inflammatory Diseases Treatment Market Share (2019-2020)
Table 40. Europe Immune-Mediated Inflammatory Diseases Treatment Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Immune-Mediated Inflammatory Diseases Treatment Market Share by Type (2015-2020)
Table 42. Europe Immune-Mediated Inflammatory Diseases Treatment Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Immune-Mediated Inflammatory Diseases Treatment Market Share by Application (2015-2020)
Table 44. China Key Players Immune-Mediated Inflammatory Diseases Treatment Revenue (2019-2020) (Million US$)
Table 45. China Key Players Immune-Mediated Inflammatory Diseases Treatment Market Share (2019-2020)
Table 46. China Immune-Mediated Inflammatory Diseases Treatment Market Size by Type (2015-2020) (Million US$)
Table 47. China Immune-Mediated Inflammatory Diseases Treatment Market Share by Type (2015-2020)
Table 48. China Immune-Mediated Inflammatory Diseases Treatment Market Size by Application (2015-2020) (Million US$)
Table 49. China Immune-Mediated Inflammatory Diseases Treatment Market Share by Application (2015-2020)
Table 50. Japan Key Players Immune-Mediated Inflammatory Diseases Treatment Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Immune-Mediated Inflammatory Diseases Treatment Market Share (2019-2020)
Table 52. Japan Immune-Mediated Inflammatory Diseases Treatment Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Immune-Mediated Inflammatory Diseases Treatment Market Share by Type (2015-2020)
Table 54. Japan Immune-Mediated Inflammatory Diseases Treatment Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Immune-Mediated Inflammatory Diseases Treatment Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Immune-Mediated Inflammatory Diseases Treatment Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Immune-Mediated Inflammatory Diseases Treatment Market Share (2019-2020)
Table 58. Southeast Asia Immune-Mediated Inflammatory Diseases Treatment Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Immune-Mediated Inflammatory Diseases Treatment Market Share by Type (2015-2020)
Table 60. Southeast Asia Immune-Mediated Inflammatory Diseases Treatment Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Immune-Mediated Inflammatory Diseases Treatment Market Share by Application (2015-2020)
Table 62. India Key Players Immune-Mediated Inflammatory Diseases Treatment Revenue (2019-2020) (Million US$)
Table 63. India Key Players Immune-Mediated Inflammatory Diseases Treatment Market Share (2019-2020)
Table 64. India Immune-Mediated Inflammatory Diseases Treatment Market Size by Type (2015-2020) (Million US$)
Table 65. India Immune-Mediated Inflammatory Diseases Treatment Market Share by Type (2015-2020)
Table 66. India Immune-Mediated Inflammatory Diseases Treatment Market Size by Application (2015-2020) (Million US$)
Table 67. India Immune-Mediated Inflammatory Diseases Treatment Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Immune-Mediated Inflammatory Diseases Treatment Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Immune-Mediated Inflammatory Diseases Treatment Market Share (2019-2020)
Table 70. Central & South America Immune-Mediated Inflammatory Diseases Treatment Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Immune-Mediated Inflammatory Diseases Treatment Market Share by Type (2015-2020)
Table 72. Central & South America Immune-Mediated Inflammatory Diseases Treatment Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Immune-Mediated Inflammatory Diseases Treatment Market Share by Application (2015-2020)
Table 74. GlaxoSmithKline Company Details
Table 75. GlaxoSmithKline Business Overview
Table 76. GlaxoSmithKline Product
Table 77. GlaxoSmithKline Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2015-2020) (Million US$)
Table 78. GlaxoSmithKline Recent Development
Table 79. Eli Lilly Company Details
Table 80. Eli Lilly Business Overview
Table 81. Eli Lilly Product
Table 82. Eli Lilly Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2015-2020) (Million US$)
Table 83. Eli Lilly Recent Development
Table 84. AstraZeneca Company Details
Table 85. AstraZeneca Business Overview
Table 86. AstraZeneca Product
Table 87. AstraZeneca Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2015-2020) (Million US$)
Table 88. AstraZeneca Recent Development
Table 89. Bristol-Myers Company Details
Table 90. Bristol-Myers Business Overview
Table 91. Bristol-Myers Product
Table 92. Bristol-Myers Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2015-2020) (Million US$)
Table 93. Bristol-Myers Recent Development
Table 94. Sanofi Company Details
Table 95. Sanofi Business Overview
Table 96. Sanofi Product
Table 97. Sanofi Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2015-2020) (Million US$)
Table 98. Sanofi Recent Development
Table 99. Roche Company Details
Table 100. Roche Business Overview
Table 101. Roche Product
Table 102. Roche Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2015-2020) (Million US$)
Table 103. Roche Recent Development
Table 104. Enlivex Therapeutics Company Details
Table 105. Enlivex Therapeutics Business Overview
Table 106. Enlivex Therapeutics Product
Table 107. Enlivex Therapeutics Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2015-2020) (Million US$)
Table 108. Enlivex Therapeutics Recent Development
Table 109. Immune Pharmaceuticals Business Overview
Table 110. Immune Pharmaceuticals Product
Table 111. Immune Pharmaceuticals Company Details
Table 112. Immune Pharmaceuticals Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2015-2020) (Million US$)
Table 113. Immune Pharmaceuticals Recent Development
Table 114. Tanabe Pharma Company Details
Table 115. Tanabe Pharma Business Overview
Table 116. Tanabe Pharma Product
Table 117. Tanabe Pharma Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2015-2020) (Million US$)
Table 118. Tanabe Pharma Recent Development
Table 119. Research Programs/Design for This Report
Table 120. Key Data Information from Secondary Sources
Table 121. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Immune-Mediated Inflammatory Diseases Treatment Market Share by Type: 2020 VS 2026
Figure 2. Targeted biologic therapies Features
Figure 3. Novel therapies Features
Figure 4. Global Immune-Mediated Inflammatory Diseases Treatment Market Share by Application: 2020 VS 2026
Figure 5. Hospitals Case Studies
Figure 6. Pharmacy Store Case Studies
Figure 7. Online Pharmacy Case Studies
Figure 8. Immune-Mediated Inflammatory Diseases Treatment Report Years Considered
Figure 9. Global Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Immune-Mediated Inflammatory Diseases Treatment Market Share by Regions: 2020 VS 2026
Figure 11. Global Immune-Mediated Inflammatory Diseases Treatment Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Immune-Mediated Inflammatory Diseases Treatment Market Share by Players in 2019
Figure 14. Global Top Immune-Mediated Inflammatory Diseases Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Immune-Mediated Inflammatory Diseases Treatment as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Immune-Mediated Inflammatory Diseases Treatment Revenue in 2019
Figure 16. North America Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018
Figure 24. GlaxoSmithKline Revenue Growth Rate in Immune-Mediated Inflammatory Diseases Treatment Business (2015-2020)
Figure 25. Eli Lilly Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Eli Lilly Revenue Growth Rate in Immune-Mediated Inflammatory Diseases Treatment Business (2015-2020)
Figure 27. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. AstraZeneca Revenue Growth Rate in Immune-Mediated Inflammatory Diseases Treatment Business (2015-2020)
Figure 29. Bristol-Myers Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Bristol-Myers Revenue Growth Rate in Immune-Mediated Inflammatory Diseases Treatment Business (2015-2020)
Figure 31. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Sanofi Revenue Growth Rate in Immune-Mediated Inflammatory Diseases Treatment Business (2015-2020)
Figure 33. Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Roche Revenue Growth Rate in Immune-Mediated Inflammatory Diseases Treatment Business (2015-2020)
Figure 35. Enlivex Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Enlivex Therapeutics Revenue Growth Rate in Immune-Mediated Inflammatory Diseases Treatment Business (2015-2020)
Figure 37. Immune Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Immune Pharmaceuticals Revenue Growth Rate in Immune-Mediated Inflammatory Diseases Treatment Business (2015-2020)
Figure 39. Tanabe Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. Tanabe Pharma Revenue Growth Rate in Immune-Mediated Inflammatory Diseases Treatment Business (2015-2020)
Figure 41. Bottom-up and Top-down Approaches for This Report
Figure 42. Data Triangulation
Figure 43. Key Executives Interviewed
Keyplayers in Global Immune-Mediated Inflammatory Diseases Treatment Market Size, Status and Forecast 2020-2026
GlaxoSmithKlineEli Lilly
AstraZeneca
Bristol-Myers
Sanofi
Roche
Enlivex Therapeutics
Immune Pharmaceuticals
Tanabe Pharma